Conway Simon Alexander Malcolm 4

What Happened

Director Simon Conway (listed as Conway Simon Alexander Malcolm) acquired a total of 784,128 shares of SRx Health Solutions, Inc. via two awards (transaction code A). On 2025-08-25 he was awarded 154,128 shares at $0.40 each (value $61,651). On 2025-12-03 he was awarded 630,000 shares at $0.39 each (value $245,700). Combined value of the awards is approximately $307,351. These were grants/awards (compensation-style acquisitions), not open-market purchases or sales.

Key Details

• Transaction types: Awards/Grants (SEC code A)
• Dates and terms:
  • 2025-08-25 — 154,128 shares @ $0.40; value ≈ $61,651
  • 2025-12-03 — 630,000 shares @ $0.39; value ≈ $245,700
• Total shares awarded: 784,128; total approximate value: $307,351
• Shares owned after the transactions: not disclosed in the provided filing excerpt
• Filing timeliness: Form 4 was filed 2026-04-03 covering a 2025-08-25 period — this appears to be a late filing (insiders normally must file within two business days). Late filing is typically corrected by the submission but may draw regulatory attention.

Context

• Awards (code A) are usually compensation or director grants and do not carry the same market-sentiment signal as open-market purchases by insiders. They often have vesting or transfer restrictions.
• Because these were awards (not purchases or sales), they should be interpreted as compensation-related stock issuance rather than a direct personal investment decision.
• No footnotes (e.g., 10b5-1, tax withholding, or cashless sale) were provided in the data you supplied.